Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Dolby Laboratories (DLB) EBIAT (2016 - 2025)

Historic EBIAT for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to $53.7 million.

  • Dolby Laboratories' EBIAT fell 2113.85% to $53.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $242.1 million, marking a year-over-year decrease of 857.31%. This contributed to the annual value of $256.5 million for FY2025, which is 296.01% down from last year.
  • Per Dolby Laboratories' latest filing, its EBIAT stood at $53.7 million for Q4 2025, which was down 2113.85% from $49.7 million recorded in Q3 2025.
  • Dolby Laboratories' 5-year EBIAT high stood at $98.2 million for Q1 2024, and its period low was $9.9 million during Q3 2023.
  • For the 5-year period, Dolby Laboratories' EBIAT averaged around $56.8 million, with its median value being $54.2 million (2021).
  • In the last 5 years, Dolby Laboratories' EBIAT tumbled by 6430.32% in 2023 and then soared by 49412.6% in 2024.
  • Dolby Laboratories' EBIAT (Quarter) stood at $80.0 million in 2021, then decreased by 0.71% to $79.4 million in 2022, then dropped by 14.94% to $67.6 million in 2023, then rose by 0.72% to $68.1 million in 2024, then fell by 21.14% to $53.7 million in 2025.
  • Its EBIAT stands at $53.7 million for Q4 2025, versus $49.7 million for Q3 2025 and $46.5 million for Q2 2025.